Imidazolyl ethanamide pentandioic acid
Term · Oncology and biomedicine · MLC-T-ONC-014373
An orally bioavailable small molecule, with potential hematopoiesis inducing and antiviral activities. Upon oral administration, myelo001 stimulates the differentiation of bone marrow cells of the leukocytic, lymphocytic, and erythrocytic lineages, and prevents apoptosis of hematopoietic cells. This prevents chemotherapy-induced neutropenia (CIN), inhibits the risk of infections, increases tolerance and allows for the continuation of the neutropenia-inducing chemotherapeutic agent. In addition, myelo 001 has antiviral properties.
| Identifier | MLC-T-ONC-014373 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Dicarbamin; pentanedioic acid imidazolyl ethanamide |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014373",
"term": "Imidazolyl ethanamide pentandioic acid",
"field": "Oncology and biomedicine",
"definition": "An orally bioavailable small molecule, with potential hematopoiesis inducing and antiviral activities. Upon oral administration, myelo001 stimulates the differentiation of bone marrow cells of the leukocytic, lymphocytic, and erythrocytic lineages, and prevents apoptosis of hematopoietic cells. This prevents chemotherapy-induced neutropenia (CIN), inhibits the risk of infections, increases tolerance and allows for the continuation of the neutropenia-inducing chemotherapeutic agent. In addition, myelo 001 has antiviral properties.",
"synonyms": [
"Dicarbamin",
"pentanedioic acid imidazolyl ethanamide"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/imidazolyl-ethanamide-pentandioic-acid/"
}
Record 9,050 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.